Neutralisation sensitivity of the SARS-CoV-2 omicron BA.2.75 sublineage

Standard

Neutralisation sensitivity of the SARS-CoV-2 omicron BA.2.75 sublineage. / Gruell, Henning; Vanshylla, Kanika; Tober-Lau, Pinkus; Hillus, David; Sander, Leif Erik; Kurth, Florian; Klein, Florian.

In: LANCET INFECT DIS, Vol. 22, No. 10, 10.2022, p. 1422-1423.

Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

Harvard

Gruell, H, Vanshylla, K, Tober-Lau, P, Hillus, D, Sander, LE, Kurth, F & Klein, F 2022, 'Neutralisation sensitivity of the SARS-CoV-2 omicron BA.2.75 sublineage', LANCET INFECT DIS, vol. 22, no. 10, pp. 1422-1423. https://doi.org/10.1016/S1473-3099(22)00580-1

APA

Gruell, H., Vanshylla, K., Tober-Lau, P., Hillus, D., Sander, L. E., Kurth, F., & Klein, F. (2022). Neutralisation sensitivity of the SARS-CoV-2 omicron BA.2.75 sublineage. LANCET INFECT DIS, 22(10), 1422-1423. https://doi.org/10.1016/S1473-3099(22)00580-1

Vancouver

Gruell H, Vanshylla K, Tober-Lau P, Hillus D, Sander LE, Kurth F et al. Neutralisation sensitivity of the SARS-CoV-2 omicron BA.2.75 sublineage. LANCET INFECT DIS. 2022 Oct;22(10):1422-1423. https://doi.org/10.1016/S1473-3099(22)00580-1

Bibtex

@article{1cf0b8af891a4f0ea8afba593286fbf6,
title = "Neutralisation sensitivity of the SARS-CoV-2 omicron BA.2.75 sublineage",
keywords = "Antibodies, Viral, COVID-19, Humans, SARS-CoV-2",
author = "Henning Gruell and Kanika Vanshylla and Pinkus Tober-Lau and David Hillus and Sander, {Leif Erik} and Florian Kurth and Florian Klein",
year = "2022",
month = oct,
doi = "10.1016/S1473-3099(22)00580-1",
language = "English",
volume = "22",
pages = "1422--1423",
journal = "LANCET INFECT DIS",
issn = "1473-3099",
publisher = "Lancet Publishing Group",
number = "10",

}

RIS

TY - JOUR

T1 - Neutralisation sensitivity of the SARS-CoV-2 omicron BA.2.75 sublineage

AU - Gruell, Henning

AU - Vanshylla, Kanika

AU - Tober-Lau, Pinkus

AU - Hillus, David

AU - Sander, Leif Erik

AU - Kurth, Florian

AU - Klein, Florian

PY - 2022/10

Y1 - 2022/10

KW - Antibodies, Viral

KW - COVID-19

KW - Humans

KW - SARS-CoV-2

U2 - 10.1016/S1473-3099(22)00580-1

DO - 10.1016/S1473-3099(22)00580-1

M3 - Other (editorial matter etc.)

C2 - 36084664

VL - 22

SP - 1422

EP - 1423

JO - LANCET INFECT DIS

JF - LANCET INFECT DIS

SN - 1473-3099

IS - 10

ER -